SR
RMD icon

Swiss Re’s ResMed RMD Stock Holding History

Swiss Re’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Hold
70
– – 0.1% 162
2025
Q4 		$16.9K Buy
+70
New +$17.9K ﹤0.01% 154

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss Re's RMD Position: Q1 2026 in Review

Swiss Re held its ResMed (RMD) position steady in Q1 2026 at 70 shares worth $15.7K. The position accounts for 0.1% of the portfolio, ranked #162.

Swiss Re first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $16.9K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Swiss Re held 70 shares of ResMed worth $15.7K as of Q1 2026.
  • Swiss Re left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.1% of Swiss Re's portfolio in Q1 2026, its #162 holding.
  • Swiss Re first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Swiss Re's ResMed position peaked at $16.9K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.